脓毒症诱发的轻中度急性呼吸窘迫综合征患者无创通气失败因素

doi:10.3969/j.issn.1004-583X.2018.11.011

临床荟萃

脓毒症诱发的轻中度急性呼吸窘迫综合征患者无创通气失败因素

1.保定市第一医院重症医学科, 河北保定 071000；2.河北医科大学第三医院急诊科, 河北石家庄 050000

出版日期:2018-11-05 发布日期:2018-12-10
通讯作者: 通信作者：董士民, Email: dsm_123@163.com

Factors for the failure of noninvasive positive pressure ventilation for patients with mild or moderate acute respiratory distress syndrome induced by sepsis

1.Intensive Care Unit, Baoding First Hospital, Baoding 071000, China; 2.Department of Emergency,
the Third Hospital of Hebei Medical University, Shijiazhuang 050000, China

Online:2018-11-05 Published:2018-12-10
Contact: Corresponding author: Dong Shimin, Email: dsm_123@163.com

摘要/Abstract

摘要： 目的评价无创正压通气(NPPV)用于脓毒症诱发的轻、中度急性呼吸窘迫综合征(ARDS)的疗效及安全性，分析NPPV治疗失败的相关危险因素，以期更好地把握NPPV转为有创正压通气(IPPV)治疗的时机。方法采用回顾性研究方法，选取2013-2018年保定市第一医院重症医学科收治的严重脓毒血症合并ARDS的患者共78例，56例患者符合要求纳入研究。所有患者，均首先接受NPPV治疗，按无创通气后是否再行有创通气将患者分为成功组和失败组。观察两组入院时基本情况，应用无创通气的相关指标，观察两组无创通气前及无创通气2小时后生命体征、血气分析及氧合指数，最后对两组的ICU停留时间、住院时间、住院死亡率进行比较。分析与NPPV治疗失败的相关独立危险因素。结果 56例患者，成功组36例（64.3%），失败组20例（35.7%）。与成功组比较，失败组的平均年龄高、急性生理与慢性健康评分(APACHEⅡ)高、因肺部感染导致的ARDS的比例较高（P均<0.05），NPPV治疗2小时后成功组的氧合指数(PaO2/FiO2)较失败组明显改善（P<0.01）；通过Logistic回归分析发现，APACHEⅡ评分高（P=0.039）、NPPV 2小时后氧合指数仍<145 mmHg（P=0.000）、NPPV治疗2小时后呼吸频率仍>30次/min（P=0.016）、因肺部感染导致的ARDS（P=0.026）是NPPV治疗失败的独立危险因素。结论无创通气是治疗脓毒症诱发的轻、中度ARDS的有效方法，且有较好的安全性。患者APACHEⅡ评分高、NPPV2小时后氧合指数仍<145 mmHg、NPPV治疗2小时后呼吸频率仍>30次/min、因肺部感染导致的ARDS是预测NPPV失败的独立危险因素。

关键词: 通气, 人工, 脓毒症, 呼吸窘迫综合征, 因素分析, 统计学

Abstract: Objective To evaluate the clinical efficacy and safety of noninvasive positive pressure ventilation(NPPV) for patients with mild or moderate acute respiratory distress syndrome（ARDS） induced by sepsis, and to analyze the independent risk factors of NPPV treatment failure. Methods A retrospective observation was conducted. NPPV was used for mild or moderate ARDS patients induced by sepsis who admitted to Intensive Care Unit of Baoding First Hospital from January 2013 to December 2018. Fiftysix patients with ARDS treated with NPPV，according to whether patients needed invasive ventilation finally, were divided into success group and failure group. The data included general state, Acute Physiology and Chronic Health Evalution Ⅱ (APACHEⅡ) score，ARDS cause, NPPV related parameters, vital signs and blood gas analysis before and after NPPV. Results Of all the patients, 36 fell into the success group, while 20 (35.7%) were included failure group. The multivariate analysis showed that higher APACHEⅡ score（P=0.039），PaO2/ FiO2<145 mmHg after two hours of NPPV（P=0.000）, RR>30 times/min after two hours of NPPV（P=0.016）, and pulmonary infection derived ARDS（P=0.026） were the independent risk factors of NPPV treatment failure．Conclusion NPPV might be an effective and safe method for treatment of patients with mild or moderate ARDS induced by sepsis. The independent risk factors associated with failure of NPPV were higher APACHEⅡ score, PaO2/FiO2 <145 mmHg after two hours of NPPV, RR>30 times/min after two hours of NPPV, and pulmonary infection derived ARDS.

Key words: ventilation, artificial；sepsis； respiratory distress syndrome；factor analysis, , statistical

王虹1，董士民2，赵顺成1，王琳1，张中学1，刘洪波1，褚娅琨1，陈亚静1. 脓毒症诱发的轻中度急性呼吸窘迫综合征患者无创通气失败因素[J]. 临床荟萃, doi: 10.3969/j.issn.1004-583X.2018.11.011.

Wang Hong1, Dong Shimin2, Zhao Shuncheng1, Wang Lin1, Zhang Zhongxue1, . Factors for the failure of noninvasive positive pressure ventilation for patients with mild or moderate acute respiratory distress syndrome induced by sepsis[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2018.11.011.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2018.11.011

https://huicui.hebmu.edu.cn/CN/Y2018/V33/I11/966

[1]	黄赛虎, 龙中洁, 董兴强, 孟祥营, 吴水燕, 柏振江. 血液肿瘤患儿合并脓毒血症的病原学特点及临床特征[J]. 临床荟萃, 2024, 39(1): 38-42.
[2]	赵欣, 柳云. 生成式人工智能赋能医学人文教育的伦理审视[J]. 临床荟萃, 2024, 39(1): 65-69.
[3]	崔兰丹, 杨春燕. 脓毒症患者甲状腺激素的变化特点及研究进展[J]. 临床荟萃, 2024, 39(1): 70-74.
[4]	杨旻星, 孙璐, 叶赟, 徐文东, 黄小琳, 张海云, 徐英蕾. 中青年2型糖尿病合并阻塞性睡眠呼吸暂停低通气综合征患者认知功能特点及其影响因素[J]. 临床荟萃, 2023, 38(3): 216-220.
[5]	唐爱军, 汪丽韡. 脓毒症患者入院时血小板计数及凝血指标对28天生存状况的预测价值[J]. 临床荟萃, 2023, 38(3): 250-254.
[6]	梁炳松, 李育英, 张岐平, 陈英道, 李健. 替罗非班治疗进展性穿支动脉梗死临床疗效的相关因素[J]. 临床荟萃, 2023, 38(12): 1091-1094.
[7]	白碧玥, 彭艳, 朱晓峰, 尹昌浩. 缺血性脑卒中影响侧支循环建立因素的研究进展[J]. 临床荟萃, 2023, 38(11): 1034-1037.
[8]	郑志璇, 平芬, 李萍, 吴国飘. 阻塞性睡眠呼吸暂停低通气综合征与支气管哮喘关系的研究进展[J]. 临床荟萃, 2023, 38(10): 940-943.
[9]	未培轩, 兰晓敬, 吴亭亭, 史俊峰, 薛延英, 王景梅. 间断喂养与持续喂养对行机械通气患者耐受性、营养指标及预后的影响[J]. 临床荟萃, 2023, 38(10): 907-911.
[10]	周利娟, 诸彭伟, 曹梅, 程真梅, 吴峤微, 李勇. 铁蛋白、红细胞参数及血浆D-二聚体与儿童脓毒症的相关性[J]. 临床荟萃, 2023, 38(1): 60-63.
[11]	张文超, 李建立. 全身麻醉期间个体化呼气末正压研究进展[J]. 临床荟萃, 2022, 37(7): 668-672.
[12]	周彬, 曾词正, 黄宇戈, 钟娩玲, 吴家园. pSOFA评分联合C-反应蛋白、降钙素原在脓毒症患儿预后评估中的作用[J]. 临床荟萃, 2022, 37(7): 616-622.
[13]	张志萍, 张宝民, 秦伟, 高凌杰, 陈冬. 肠内营养支持对慢性阻塞性肺病急性加重期机械通气患者营养和预后的影响[J]. 临床荟萃, 2022, 37(6): 510-514.
[14]	张孟媛, 朱勇. 降钙素原清除率及序贯器官衰竭估计评分对脓毒症患者预后的预测价值[J]. 临床荟萃, 2022, 37(3): 225-229.
[15]	肖刘牛, 钟燕霞, 李树生. 体外血液净化技术对脓毒症临床预后及细胞因子影响的Meta分析[J]. 临床荟萃, 2022, 37(1): 5-13.

脓毒症诱发的轻中度急性呼吸窘迫综合征患者无创通气失败因素

Factors for the failure of noninvasive positive pressure ventilation for patients with mild or moderate acute respiratory distress syndrome induced by sepsis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价